Etoposide and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Etoposide and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: etoposide
Brand name: VePesid, Etopophos, Toposar
Synonyms: n.a.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Etoposide-Insulin degludec Subcutaneous
- Etoposide-Insulin detemir
- Etoposide-Insulin Detemir (Cartridges and Prefilled Syringes)
- Etoposide-Insulin Detemir (Vials)
- Etoposide-Insulin detemir Subcutaneous
- Etoposide-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Etoposide Capsule
- Insulin degludec and liraglutide Subcutaneous-Etoposide Capsules
- Insulin degludec and liraglutide Subcutaneous-Etoposide injection
- Insulin degludec and liraglutide Subcutaneous-Etoposide Oral, Intravenous
- Insulin degludec and liraglutide Subcutaneous-Etoposide phosphate
- Insulin degludec and liraglutide Subcutaneous-Etrafon